Washington Trust Bank’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Washington Trust Bank’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-13	Closed	-$2K	–	1202
2016 Q2	$2K	Sell	13 -12	-48%	-$1.75K	﹤0.01%	763
2016 Q1	$3K	Hold	25	–	–	﹤0.01%	684
2015 Q4	$4K	Hold	25	–	–	﹤0.01%	675
2015 Q3	$4K	Hold	25	–	–	﹤0.01%	702
2015 Q2	$6K	Hold	25	–	–	﹤0.01%	712
2015 Q1	$7K	Buy	+25	New	+$5.41K	﹤0.01%	710

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Washington Trust Bank's ICPT Position: Q3 2016 in Review

Washington Trust Bank sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2016, closing a stake of 13 shares — an estimated $2K sold.

Washington Trust Bank first reported a position in ICPT in Q1 2015 and held it in 6 quarters. The position peaked at $7K in Q1 2015. 172 funds tracked by Wall St. Rank hold ICPT as of Q3 2016.

Washington Trust Bank reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
Washington Trust Bank sold 13 Intercept Pharmaceuticals, Inc. shares in Q3 2016, an estimated $2K.
Washington Trust Bank first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 6 quarters.
Washington Trust Bank's Intercept Pharmaceuticals, Inc. position peaked at $7K in Q1 2015.
172 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2016.

Based on Washington Trust Bank's 13F filing for Q3 2016, filed 4 Oct 2016.